ArticleAnnals of intensive care2012

Design, conduct, and analysis of a multicenter, pharmacogenomic, biomarker study in matched patients with severe sepsis treated with or without drotrecogin Alfa (activated).

Djillali Annane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.